Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a)

作者: Martina F. Kronenberg , Paul König , Gerd Utermann , Hans Dieplinger , Florian Kronenberg

DOI: 10.1046/J.1523-1755.1998.00086.X

关键词:

摘要: Influence of hematocrit on the measurement lipoproteins demonstrated by example lipoprotein(a). Background The many parameters human blood is usually performed in plasma or serum. Since apolipoproteins, for example, are found almost exclusively fraction after low-speed centrifugation, these can be expected to distributed a different volume depending value. Therefore, measured levels might relatively too low high comparison whole concentrations case abnormal levels. aim our experiments was evaluate extent differences between and concentrations, taking as an lipoprotein(a) [Lp(a)] hemodialysis patients with documented decreased values. Methods Lp(a) well 15 values (0.29 ± 0.02) 11 control subjects (0.45 0.04). Results Plasma were 27% higher than controls (19.7 vs. 15.5mg/dl). relative difference twice (59%) when (13.5 8.5mg/dl). Similar observed 125 256 calculated formula \[ L p \( \) pasma * 1 − h e m t o c r i \] . Conclusions Our findings clearly demonstrate that strong confounding variable lipoprotein epidemiological studies plasma, especially cases Furthermore, investigating longitudinal changes should consider potential changes.

参考文章(22)
H J Parra, H Mezdour, C Cachera, M Dracon, A Tacquet, J C Fruchart, Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clinical Chemistry. ,vol. 33, pp. 721- 721 ,(1987) , 10.1093/CLINCHEM/33.5.721
Eric G. Ball, Joseph F. Sadusk, A study of the estimation of sodium in blood serum. Journal of Biological Chemistry. ,vol. 113, pp. 661- 674 ,(1936) , 10.1016/S0021-9258(18)74839-4
J. C. Franson, Specimen collection and preservation Information and Technology Report. pp. 7- 12 ,(1999)
Celina Edelstein, Angelo M. Scanu, [5] Precautionary measures for collecting blood destined for lipoprotein isolation Methods in Enzymology. ,vol. 128, pp. 151- 155 ,(1986) , 10.1016/0076-6879(86)28065-9
Kyoko Hirata, Shuichi Kikuchi, Keijiro Saku, Shiro Jimi, B.o. Zhang, Setsuya Naito, Hideo Hamaguchi, Kikuo Arakawa, Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus Kidney International. ,vol. 44, pp. 1062- 1070 ,(1993) , 10.1038/KI.1993.349
H Dieplinger, C Lackner, F Kronenberg, C Sandholzer, K Lhotta, F Hoppichler, H Graf, P König, Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). Journal of Clinical Investigation. ,vol. 91, pp. 397- 401 ,(1993) , 10.1172/JCI116213
Florian Kronenberg, Armin Steinmetz, Gerhard M. Kostner, Hans Dieplinger, Lipoprotein(a) in health and disease. Critical Reviews in Clinical Laboratory Sciences. ,vol. 33, pp. 495- 543 ,(1996) , 10.3109/10408369609080056
Gérard M. London, Tilman B. Drüeke, Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney International. ,vol. 51, pp. 1678- 1695 ,(1997) , 10.1038/KI.1997.233
W. Bürgi, R. Richterich, M. L. Mittelholzer, Der Einfluß der Enteiweißung auf die Resultate von Serum- und Plasma-Analysen Journal of Molecular Medicine. ,vol. 45, pp. 83- 86 ,(1967) , 10.1007/BF01747968